- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Subfertility.
Displaying page 1 of 1.
EudraCT Number: 2010-023867-17 | Sponsor Protocol Number: S52775 | Start Date*: 2011-03-25 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in IUI cycles stimulated with gonadotrophins: a prospective randomized multicentre study. | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-004429-34 | Sponsor Protocol Number: 2017.lipiodol.flush | Start Date*: 2018-02-15 | |||||||||||
Sponsor Name:UZ Brussel | |||||||||||||
Full Title: Histological and Transcriptional Changes caused by Endometrial Flushing with Lipiodol: A Cross Over Study. | |||||||||||||
Medical condition: Female subfertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000993-32 | Sponsor Protocol Number: S55300 | Start Date*: 2013-05-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? A RCT | ||||||||||||||||||
Medical condition: endometriosis, subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002000-13 | Sponsor Protocol Number: rFSHdosingfinding.2018 | Start Date*: 2019-01-09 | |||||||||||
Sponsor Name:University hospital Brussel | |||||||||||||
Full Title: Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study. | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002689-68 | Sponsor Protocol Number: NL.23273.08 | Start Date*: 2009-03-10 | |||||||||||
Sponsor Name:Isala Klinieken, location Sophia | |||||||||||||
Full Title: Cryo-thawed embryo transfer: natural versus artificial cycle. A non inferiority trial. | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012847-40 | Sponsor Protocol Number: Pergoveris_Cetrorelix_1 | Start Date*: 2009-11-11 | |||||||||||
Sponsor Name:NHS Lothian [...] | |||||||||||||
Full Title: A Randomised Study Comparing Two Different Regimens of Ovarian Stimulation Using Pergoveris and Cetrorelix for Controlled Ovarian Superovulation in Assisted Conception Treatment. | |||||||||||||
Medical condition: Subfertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000689-13 | Sponsor Protocol Number: HRT1vs2week.2018 | Start Date*: 2018-07-11 | |||||||||||
Sponsor Name:University hospital Brussel | |||||||||||||
Full Title: Clinical pregnancy rate for frozen embryo transfer with HRT: a pilot study comparing 1 versus 2 weeks of treatment | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001034-18 | Sponsor Protocol Number: NL43131-018-13 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:AMC Amsterdam | |||||||||||||
Full Title: Super ovulation in intrauterine insemination: FSH or Clomifene citrate | |||||||||||||
Medical condition: Women diagnosed with unexplained subfertility or mild male factor subfertility with an indication for intra uterine insemination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005005-12 | Sponsor Protocol Number: D2.D12.Bemfola | Start Date*: 2018-05-28 | ||||||||||||||||
Sponsor Name:UZ Brussel | ||||||||||||||||||
Full Title: Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | ||||||||||||||||||
Medical condition: Subfertility Oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000106-29 | Sponsor Protocol Number: T5/2013 | Start Date*: 2013-03-19 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: GnRH analog as a luteal phase support in frozen-thawed embryo transfer cycles. A Pilot study | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001124-20 | Sponsor Protocol Number: PCOS-5 | Start Date*: 2005-04-18 |
Sponsor Name:Sigrun Kjøtrød | ||
Full Title: Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective, randomised, double blind, multicenter study. | ||
Medical condition: Polycystic ovary syndrome (PCOS) is a disorder characterized by polycystic ovaries, oligo-amenorrhea and hyperandrogenism. It is the most common endocrine disorder in women of fertile age. PCOS wom... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) SE (Completed) FI (Completed) GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001014-15 | Sponsor Protocol Number: S61372 | Start Date*: 2018-06-26 |
Sponsor Name:university hospital leuven | ||
Full Title: Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial | ||
Medical condition: Patients with subfertility having frozen embryos after in vitro fertilization (IVF) or intracytoplasmatic sperm injection (ICSI) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001708-39 | Sponsor Protocol Number: S54224 | Start Date*: 2012-06-07 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Prospective randomized trial concerning three different stimulation methods in IVF/ICSI treatment in poor responders | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001307-35 | Sponsor Protocol Number: FE999906 CS004 | Start Date*: 2005-12-22 | |||||||||||
Sponsor Name:Ferring Arzneimittel GmbH | |||||||||||||
Full Title: A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered... | |||||||||||||
Medical condition: sub fertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002310-16 | Sponsor Protocol Number: LHinPOR001 | Start Date*: 2023-02-01 |
Sponsor Name:UZ Brussel | ||
Full Title: Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders. | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001835-22 | Sponsor Protocol Number: MONACO | Start Date*: 2021-10-20 |
Sponsor Name:Ghent University Hospital | ||
Full Title: A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MNC) in expected and established poor responders | ||
Medical condition: this study will compare the efficacy of two different strategies for the management of predicted low prognosis patients under stimulation for IVF/ICSI: up to three MNCs (Modified Natural Cycle) (c... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004985-21 | Sponsor Protocol Number: BGB-A317-A1217-302(AdvanTIG-302) | Start Date*: 2021-09-01 | |||||||||||
Sponsor Name:BeiGene, Ltd. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab in Patients With Previously Untreated, PD L1 Selected, a... | |||||||||||||
Medical condition: Previously Untreated, PD-L1-Selected, and Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) FR (Trial now transitioned) NL (Trial now transitioned) IT (Trial now transitioned) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
